For a man with benign prostatic hyperplasia and mild erectile dysfunction, should tadalafil (Cialis) be taken daily or as needed?

Daily Tadalafil 5mg is the Preferred Option for BPH with Mild ED

For a man with benign prostatic hyperplasia and mild erectile dysfunction, tadalafil (Cialis) 5mg once daily should be prescribed rather than as-needed dosing, as this is the only FDA-approved regimen that simultaneously treats both conditions and provides continuous symptom relief for LUTS while maintaining erectile function improvement. 1

Rationale for Daily Dosing

The FDA has specifically approved tadalafil 5mg once daily for the treatment of both BPH-associated lower urinary tract symptoms (LUTS) and erectile dysfunction, either as separate conditions or when they coexist 1. This is a critical distinction—the as-needed (PRN) formulations are only FDA-approved for erectile dysfunction, not for BPH 1.

Evidence Supporting Daily Tadalafil for Dual Indication

The 2018 AUA Erectile Dysfunction Guideline notes that on-demand dosing versus daily dosing for tadalafil produces the same level of efficacy for ED alone 2. However, this equivalence only applies when treating ED in isolation. When BPH is present, the situation changes fundamentally.

The 2021 AUA BPH Guideline provides a Moderate Recommendation (Evidence Level: Grade B) that 5mg daily tadalafil should be discussed as a treatment option for patients with LUTS/BPH irrespective of comorbid erectile dysfunction 3. Importantly, the guideline specifically advises against combining low-dose daily 5mg tadalafil with alpha blockers, as it offers no advantages in symptom improvement over either agent alone 3.

Clinical Efficacy Data

Multiple high-quality studies demonstrate that tadalafil 5mg once daily:

• Significantly improves International Prostate Symptom Score (IPSS) with reductions of approximately 5.6 points from baseline, with effects apparent as early as 1 week and statistically significant by 4 weeks 4
• Improves both voiding and storage subscores of the IPSS 5
• Enhances quality of life measures including BPH Impact Index (BII) 6, 4
• Simultaneously improves erectile function in men with comorbid ED, with significant improvements in IIEF-EF scores 6

A pivotal 12-week randomized controlled trial showed tadalafil 5mg daily reduced IPSS by -6.1 points compared to -3.8 points with placebo (p<0.001), while also significantly improving erectile function 6.

Why PRN Dosing is Inadequate for This Patient

As-needed tadalafil cannot provide continuous relief of BPH symptoms, which are present throughout the day and night, not just during sexual activity. The mechanism of action for BPH benefit involves:

• Relaxation of smooth muscle in the prostate, bladder neck, and urethra through the NO-cGMP-PDE5 pathway 7
• Improvement in bladder compliance and reduction in detrusor overactivity 8
• Potential improvement in endothelial function and vascular health 8

These effects require sustained drug levels, which only daily dosing provides.

Practical Prescribing Approach

Starting Regimen

• Tadalafil 5mg once daily (not PRN)
• Can be taken with or without food 1
• Timing of daily dose can be flexible based on patient preference

Patient Counseling Points

• Explain that this medication treats both conditions simultaneously—a unique advantage over alpha-blockers or 5-alpha reductase inhibitors that may worsen sexual function
• LUTS improvement typically begins within 1 week, with maximum benefit by 4-12 weeks 4
• ED improvement may be noticed within days to weeks 6
• Sexual stimulation is still required for erectile response 2

Important Contraindications and Precautions

• Absolute contraindication: Concurrent nitrate use in any form 1
• Absolute contraindication: Concomitant guanylate cyclase stimulators 1
• Use caution with alpha-blockers due to potential additive blood pressure lowering effects 1
• Common adverse effects include headache (3.7%), back pain (3.1%), dyspepsia, and flushing—generally mild and self-limited 4

When to Avoid Combination Therapy

The 2021 AUA guideline specifically recommends against combining tadalafil 5mg daily with alpha-blockers (Moderate Recommendation; Evidence Level: Grade C) 3. If your patient is already on an alpha-blocker with good LUTS control but has new ED, you have two options:

1. Switch from alpha-blocker to tadalafil 5mg daily monotherapy
2. Use PRN tadalafil (10-20mg) for ED while continuing the alpha-blocker for BPH

Monitoring and Dose Adjustment

• Reassess LUTS (using IPSS) and erectile function at 4-12 weeks
• Do not increase to higher daily doses—5mg is the only approved daily dose for BPH 1
• If inadequate response, consider adding other BPH therapies (alpha-blocker or 5-ARI) rather than increasing tadalafil dose, though note the guideline caution about combination with alpha-blockers 3

Special Populations

Renal impairment: Use caution; dose adjustment may be needed for severe impairment 1

Hepatic impairment: Use caution with mild-moderate impairment; generally not recommended in severe disease 1

Testosterone deficiency: If present, combining testosterone therapy with PDE5 inhibitors may enhance efficacy for ED 2

Common Pitfall to Avoid

The most critical error would be prescribing PRN tadalafil (10mg or 20mg) for a patient with both BPH and ED. This approach only addresses ED during sexual activity and provides no benefit for the continuous LUTS symptoms. The patient would essentially remain untreated for their BPH, missing the opportunity for a single medication to address both conditions effectively.